View Full Profile. Learn about our Editorial Policies. Towards the final stages of diseases such as cancer and kidney disease, many patients develop cachexia, a devastating condition in which muscle ...

The experimental drug ponsegromab is a monoclonal antibody that treats the growth factor that leads to the growth of cancer ...

Publication of SARA-INT Phase II results for BIO101Confirmation of Phase 3 readinessParis, France and Cambridge, Massachusetts--(Newsfile Corp. - March 17, 2025) - Biophytis SA (FP: ALBPS) ("Biophytis ...

Screening and Referral for Health-Related Social Needs and Financial Distress: Current Processes Among National Cancer Institute Community Oncology Research Program Practices Cancer-associated ...

Cachexia is a serious yet under-recognized consequence of many chronic diseases, including heart disease, kidney disease, chronic obstructive pulmonary disease and, most notably, cancer.

Historically, cachexia has not been fully understood. Also known as wasting syndrome, cachexia is often incorrectly viewed as simply an inevitable side effect to cancer and other chronic conditions.

The work is published in the Journal of Cachexia, Sarcopenia and Muscle. "We are the first to study how certain drugs affect bones, and the results show that bimagrumab can increase the amount of ...

Considering taking supplements to treat cachexia? Below is a list of common natural remedies used to treat or reduce the symptoms of cachexia. Follow the links to read common uses, side effects ...

BEIJING, Feb. 28 (Xinhua) -- Chinese scientists have identified a cytokine produced by tumor cells as the key factor driving irreversible fat loss with the progression of cancer cachexia, a severe ...

The wasting syndrome, scientifically known as Cancer cachexia, manifests with severe weight loss, muscle loss, and loss of ...

Artificial Intelligence in Oncology: Fulfilling Its Promise While Avoiding Its Peril We would like to thank Drs Molfino and Imbimbo 1 for their thoughtful response to our Call to Improve Coding of ...